An order by President Rodrigo Duterte to limit the cost of several medicines could raise the retail prices of generic drugs, a pharmaceutical group said Wednesday.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Duque thanks Duterte for backing cap on medicine prices.
A group of drug makers said continuing its business in the Philippines "may not be viable" should government cut down prices of some 120 medicines.
Congress is deciding whether to approve the USMCA trade agreement (NAFTA 2.0).